三白草提取物抗乳腺癌转移作用及其机制研究

吕红; 邹乐兰; 麻俊超; 王珊; 刘婷; 柯小琴; 付剑江

doi:10.13422/j.cnki.syfjx.2015070123

您当前的位置：

首页 >

文章列表页 >

三白草提取物抗乳腺癌转移作用及其机制研究

药理 | 更新时间：2024-09-23

- 三白草提取物抗乳腺癌转移作用及其机制研究
- Anti-metastatic Effects of Extracts from Saururi Herba Downregulating Runx2 Activation on Breast Cancer Cell
- 中国实验方剂学杂志 2015年21卷第7期页码：123-127
- 作者机构：
- 作者简介：
- 基金信息：
  
  国家自然科学基金项目(30860375, 81160530, 81260656);江西省自然科学基金项目(2010GQY0147);教育部重点科技项目(211091)
- DOI：10.13422/j.cnki.syfjx.2015070123
  中图分类号： R285.5
- 纸质出版日期：2015
- 稿件说明：
移动端阅览
吕红, 邹乐兰, 麻俊超, 等. 三白草提取物抗乳腺癌转移作用及其机制研究[J]. 中国实验方剂学杂志, 2015,21(7):123-127.

LYU Hong, ZOU Le-lan, MA Jun-chao, et al. Anti-metastatic Effects of Extracts from Saururi Herba Downregulating Runx2 Activation on Breast Cancer Cell[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(7): 123-127.
吕红, 邹乐兰, 麻俊超, 等. 三白草提取物抗乳腺癌转移作用及其机制研究[J]. 中国实验方剂学杂志, 2015,21(7):123-127. DOI： 10.13422/j.cnki.syfjx.2015070123.

LYU Hong, ZOU Le-lan, MA Jun-chao, et al. Anti-metastatic Effects of Extracts from Saururi Herba Downregulating Runx2 Activation on Breast Cancer Cell[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(7): 123-127. DOI： 10.13422/j.cnki.syfjx.2015070123.

摘要

目的: 研究三白草提取物(extracts from Saururi Herba

ESH)的抗乳腺癌转移作用。方法: 采用尾静脉注射肿瘤细胞法建立实验性转移模型;采用体外细胞黏附、迁移以及侵袭法

观察ESH对乳腺癌细胞系MDA-MB-231细胞的体外黏附、迁移以及侵袭的影响;采用Runx2转录因子分析法和Western blot法

观察ESH对Runx2活性的影响。结果: 给药后

ESH 200

400 mg·kg-1剂量组裸鼠肺组织中人ck19的平均表达量分别为55.85%

42.28%

显著低于空白组(P < 0.01);体外黏附实验表明

ESH可干扰肿瘤细胞与细胞外基质蛋白之间的黏附(P < 0.01);ESH 80

160 g·L-1剂量组的细胞迁移细胞数分别为(106.4±52.4)

(40.4±7.6)个

与空白组相比具有统计学差异(P < 0.01);细胞侵袭实验表明

ESH低、中、高剂量组的侵袭细胞抑制率分别为32.57%

68.04%和71.92%

与空白组相比具有统计学差异(P < 0.01)。Runx2转录因子活性分析以及Western blot实验结果表明

ESH可显著抑制Runx2的磷酸化

从而抑制其转录活性。结论: ESH 具有明显的抗乳腺癌转移作用。抑制细胞内Runx2磷酸化可能是其发挥抗转移作用的机制之一。

Abstract

Objective: The study was conducted to investigate the anti-metastatic effects of extracts from Saururi Herba (ESH) and its mechanisms. Method: Balb/C Nu mice were used to establish in vivo experimental metastasis model by tail-vein injection;in vitro invasion

in vitro migration and in vitro adhesion assay were performed to determine the effects of ESH on metastatic properties of breast cancer cells;Runx2 transcription factor assay and western blot method were used to detect the effects of ESH on activation of Runx2. Result: ESH exhibited significant suppression on the formation of lung metastatic foci of breast cancer in vivo (P < 0.01). Moreover

in vitro adhesion

migration and invasion of MDA-MB-231 cells were inhibited significantly when these cells were incubated with ESH (P < 0.01). It was also shown that ESH had suppression activity of Runx2 and expression of p-Runx2 in breast cancer cells. Conclusion: ESH shows significant anti-metastatic properties. The mechanisms of this traditional Chinese medicine may be associated with suppression of Runx2 activation.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

裸花紫珠提取物的抗乳腺癌转移作用及其机制

基于巨噬细胞吞噬功能探讨六味地黄丸、二至丸、左归丸预防乳腺癌发生的机制

经典名方阳和汤的抗乳腺癌活性成分筛选

中药调控Wnt/β-catenin信号通路干预乳腺癌的研究进展

葫芦素B诱导细胞铁死亡抑制乳腺癌4T1细胞增殖作用及机制